race oncology discusses clinical progress and march quarter highlights
Published 2 years ago • 953 plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
8:00
race oncology highlights impressive bisantrene clinical data
-
0:41
race oncology achieves promising results in phase 1a-b clinical trial
-
3:15
race oncology reports final data from preclinical melanoma research program
-
5:29
revolutionary new cancer treatment at nyu
-
38:32
investor presentation
-
4:58
medical breakthrough could melt tumours in two types of cancer | 9 news australia
-
45:09
race oncology june 2022 quarterly investor briefing
-
54:51
race oncology (asx: rac) investor briefing - may 2021
-
6:49
race oncology receives positive results from aml trial of bisantrene
-
6:42
race oncology looks to accelerate clinical development of bisantrene
-
7:14
race oncology with proactive at the asx small and mid-cap conference
-
4:36
race oncology partners with george clinical for rc220 bisantrene trials
-
4:56
race oncology hits 12-month high with new multiple myeloma findings
-
13:32
race oncology asx small and mid cap conference
-
5:15
race oncology completes glp studies for rc220 bisantrene; closer to human trials
-
7:33
race oncology fields promising early results from zantrene kidney cancer program
-
5:00
race oncology secures governance approval for open-label zantrene trial
-
8:20
race oncology at the heart of cancer care
-
5:17
race oncology agm 2021 share purchase plan explained
-
19:11
sharecafe 'hidden gems' webinar - race oncology asx:rac